This brand name is authorized in Japan
The drug MARDUOX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Maxacalcitol
UNII N2UJM5NBF6 - MAXACALCITOL
|
|
|
|
2
Betamethasone
UNII 50FH5AG9RW - BETAMETHASONE BUTYRATE PROPIONATE
|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2699804M1023 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
